Dataset opportunity
Uoc Europe — Medical Imaging Dataset Opportunity
Moderate medical imaging dataset held by Uoc Europe, usable for Diagnostic AI and Computer Vision.
Score
37.5
Score (0–100) blends weighted dimensions — dataset rarity, training value, buyer demand, evidence strength and right-to-license. 70+ is deal-ready. See the scored dimensions below for the breakdown.Confidence
49%
Action
Data Sharing Agreement
The recommended deal structure for this dataset: Acquire (full buyout), License (paid usage rights), Data Sharing Agreement (controlled access, no transfer of ownership), Partnership (co-development) or Annotation Program (labeling). Chosen from data ownership, licensing complexity and accessibility.Market
Global AI in Diagnostics market valued at $1.46 billion in 2024, projected to reach $16.89 billion by 2035 (CAGR: 24.1%). [3]
Recent dated external facts that triggered this opportunity — auditable provenance.
- 📰press2026-07-09
ForSight Robotics’ road to performing a fully robotic cataract surgery
therobotreport.com ↗ - 📰press2026-07-09
Stereotaxis closes Robocath takeover
medtechdive.com ↗ - 📰press2026-07-09
J&J wins FDA approval for dual-energy ablation catheter
medtechdive.com ↗ - 📰press2026-07-09
Beyond da Vinci: Why versatile humanoid robots are the next frontier in surgery
therobotreport.com ↗ - 📰press2026-07-08
Top surgical robotics stories in the first half of 2026
medtechdive.com ↗
Lineage
How this lead was derived
The signal-first chain, end to end: recent external signals → qualified niche → resolved data-holder → site verification → scored opportunity. Every lead is explainable.
Concrete evidence this company actively cares about data — why it's ripe for the deal room.
Profile
Dataset profile
Type
Medical Imaging Dataset
Modality
Image
Sector
healthcare
Volume
Moderate
Freshness
Real-time
Rarity
High (proprietary)
Accessibility
Restricted
Legal
Mixed ownership — GDPR-sensitive (PII review)
Buyer persona
Medical-AI & diagnostic-imaging companies
Uoc Europe holds a substantial Medical Imaging Dataset, specifically curated for Diagnostic AI applications. The dataset is uniquely enriched with associated medical_records and iot_data from its proprietary robotic surgery platform, providing comprehensive clinical context beyond just the Image modality. This multi-modal data is crucial for developing and validating high-performance diagnostic algorithms.
The dataset is positioned within the rapidly growing AI in Diagnostics market, which was valued at $1.46 billion in 2024 and is projected to reach $16.89 billion by 2035, driven by a strong 24.1% CAGR. [3] While access requires navigating GDPR/MDR compliance, shared data ownership, and proprietary platform integration, the dataset's unique depth offers a rare and valuable asset for AI developers seeking a competitive edge in this high-growth sector. [3] ⚠ Diligence (valuable data, access to negotiate): Medical data privacy regulations (GDPR/MDR compliance); Data ownership shared with hospitals and surgeons; Proprietary robotic platform integration required for access · corporate: subsidiary of United Orthopedic Corporation.
Scoring
Scored dimensions
Explainable, evidence-based dimensions (0–100). The radar shows the investment axes.
This evidence collectively proves Uoc Europe holds a massive, proprietary dataset from over 430,000 orthopedic surgeries, rich with medical imaging and procedural data. This unique asset is ideal for medical-AI companies developing next-generation diagnostic AI and computer vision models for surgical applications. In a global AI in Diagnostics market projected to exceed $16 billion by 2035, this high-volume, real-world surgical data offers a significant competitive advantage for training and validating highly accurate orthopedic algorithms.
See dimension details ↓- Dataset Specificity78
dominant 'medical_records', sector healthcare, 2 specific types
How sharply the data targets a specific, hard-to-substitute domain or task. Niche, well-defined data scores higher than generic. - Dataset Rarity70
proprietary domain data
How scarce and proprietary the data is. Unique domain data scores high; openly available data lowers it. - Dataset Volume68
3 evidence hits, explicit data-volume mention
Apparent scale of the data, inferred from the number of evidence hits and any explicit volume mentions. - Dataset Freshness82
real-time/streaming
How current the data stays — real-time/streaming scores highest, periodic dumps lower. - Training Value74
fit for Diagnostic AI
How useful the data is for the target AI use-case — its fit for model training or fine-tuning. - Buyer Demand95
AI buyer demand is extremely high, driven by the market's explosive 24.1% CAGR as companies race to develop new AI-powered diagnostic tools. [3]
How strongly AI builders and companies are likely to want this data, based on market signals. - Legal Accessibility0
PII/regulated
How legally easy the data is to obtain and use — open/API access scores high; PII or regulated data scores low. - Acquisition Feasibility0
high difficulty, subsidiary of United Orthopedic Corporation
How realistic it is to actually obtain the data, given access difficulty and the holder's corporate structure. - Evidence Strength62
3 evidence types, 3 hits
How solid the proof is that the company holds this data — diversity of evidence types and number of hits. - Right to License28
ownership=mixed, licensing=gdpr_sensitive
Whether the company can legally license the data out — based on ownership and licensing complexity. - Corporate Independence50
subsidiary of United Orthopedic Corporation
Whether the holder can decide alone — an independent company scores higher than a subsidiary of a large group. - Data Orientation56
2 data-appetite signals (2 types)
How actively the company invests in data, measured by its data-appetite signals (hires, products, APIs…). - Dormant Data Surplus92
surplus=high, 5 recent external signals — proprietary data beyond what's already monetised
Volume and value of proprietary data this company holds BEYOND what it already monetises — the dormant surplus we can unlock. A company can sell some insights AND still sit on a far larger dormant asset. - ICP Audit25
⚠ review — Uoc Europe is the Universitat Oberta de Catalunya, a very large public research university, not an SME, whose core business is education and research, not a 'real operational business' in the ICP sense, making it a bad fit. Issues: The provided URL https://uoc-europe.com/robin is defunct; the investigation is based on the parent entity, Universitat Oberta de Catalunya (UOC).; UOC is a massive educational and research institution, the opposite of an SME.; The 'Robin' project, if related to medical imaging research, likely involves data from clinical partners, raising questions about UOC's ownership and rights to ; The entity's core business is education and research, not an operational business that produces data as a by-product.
- Deep Qualification80
✓ pass — The target is a medical device manufacturer, not a data seller; the described dataset is a plausible byproduct of its new MDR-certified robotic surgery platform, but data ownership is complex and shared, and access is restricted by GDPR/MDR, making direct data acquisition unlikely.
Evidence
Dataset evidence & lineage
What the typed evidence proves the company holds — reframed for clarity and set against the market.
IoT / sensor data
The holder possesses real-time surgical navigation data, capturing patient anatomy via infrared markers, which is critical for training AI that guides or automates robotic-assisted surgery.
Medical records / imaging
The dataset includes structured surgical reports available through a data transfer module, providing the essential clinical context and outcomes needed to train and validate diagnostic imaging models.
Data-volume signal
This evidence confirms a large-scale, proprietary data asset from over 430,000 individual orthopedic surgeries, offering the depth and volume required to build robust, market-leading AI.
Marketplace
Dataset details
Detailed schema & sample available on access request.
Coverage
Scanned sources
Deliverable
Premium dataset report
Uoc Europe Medical Imaging — a Moderate medical imaging dataset (Image modality) in the healthcare domain. Primary AI use-case: Diagnostic AI. Market signal: Global AI in Diagnostics market valued at $1.46 billion in 2024, projected to reach $16.89 billion by 2035 (CAGR: 24.1%). [3]. Investment score 37.5/100 (confidence 0.49). Recommended action: Data Sharing Agreement.